University of Oxford: Influenza, Human trials

The registry lists 13 Influenza, Human studies with University of Oxford as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 5Phase 2 6Phase 3 1Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingNCT05648448Phase 2
• ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and AdultsCompletedNCT02529904Phase 2
• Safety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza VaccineTerminatedNCT02014168Phase 1
• A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1CompletedNCT01818362Phase 1
• ADITEC FLU STUDY: Understanding the Genetic Basis for Immune ResponsesCompletedNCT01682369Phase 2
• A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1CompletedNCT01623518Phase 1
• Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under OneWithdrawnNCT01546935Phase 2/3
• A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza VaccineCompletedNCT01465035Phase 1
• Swine Flu (Influenza A H1N1) Follow on Vaccine StudyCompletedNCT01239537
• A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy AdultsCompletedNCT00993083Phase 2
• Swine Flu (Novel Influenza A H1N1) Vaccine StudyCompletedNCT00980850Phase 2
• Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral OseltamivirCompletedNCT00980109Phase 4
• A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy AdultsCompletedNCT00942071Phase 1